These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 18645329)

  • 1. Design and rationale of the URGENT Dyspnea study: an international, multicenter, prospective study.
    Pang PS; Tavares M; Collins SP; Cleland JG; Hollander J; Nieminen M; Miller C; Courtney DM; Kirk JD; Masip J; Parkhomenko A; Macarie C; Peacock WF; Spinar J; Nowak R; Raev D; Storrow AB; Spisak V; Hamdy A; Mebazaa A; Gheorghiade M;
    Am J Ther; 2008; 15(4):299-303. PubMed ID: 18645329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of early standard therapy on dyspnoea in patients with acute heart failure: the URGENT-dyspnoea study.
    Mebazaa A; Pang PS; Tavares M; Collins SP; Storrow AB; Laribi S; Andre S; Mark Courtney D; Hasa J; Spinar J; Masip J; Frank Peacock W; Sliwa K; Gayat E; Filippatos G; Cleland JG; Gheorghiade M
    Eur Heart J; 2010 Apr; 31(7):832-41. PubMed ID: 19906690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S3 detection as a diagnostic and prognostic aid in emergency department patients with acute dyspnea.
    Collins SP; Peacock WF; Lindsell CJ; Clopton P; Diercks DB; Hiestand B; Hogan C; Kontos MC; Mueller C; Nowak R; Chen WJ; Huang CH; Abraham WT; Amsterdam E; Breidthardt T; Daniels L; Hasan A; Hudson M; McCord J; Naz T; Wagoner LE; Maisel A
    Ann Emerg Med; 2009 Jun; 53(6):748-57. PubMed ID: 19232777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach.
    Pang PS; Cleland JG; Teerlink JR; Collins SP; Lindsell CJ; Sopko G; Peacock WF; Fonarow GC; Aldeen AZ; Kirk JD; Storrow AB; Tavares M; Mebazaa A; Roland E; Massie BM; Maisel AS; Komajda M; Filippatos G; Gheorghiade M;
    Eur Heart J; 2008 Mar; 29(6):816-24. PubMed ID: 18310669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physician vs patient assessment of dyspnea during acute decompensated heart failure.
    Smithline HA; Caglar S; Blank FS
    Congest Heart Fail; 2010; 16(2):60-4. PubMed ID: 20412470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tezosentan in patients with acute heart failure: design of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Study (VERITAS).
    Teerlink JR; McMurray JJ; Bourge RC; Cleland JG; Cotter G; Jondeau G; Krum H; Metra M; O'Connor CM; Parker JD; Torre-Amione G; Van Veldhuisen DJ; Frey A; Rainisio M; Kobrin I;
    Am Heart J; 2005 Jul; 150(1):46-53. PubMed ID: 16084150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The rationale for an acute heart failure syndromes clinical trials network.
    Collins SP; Levy PD; Lindsell CJ; Pang PS; Storrow AB; Miller CD; Naftilan AJ; Thohan V; Abraham WT; Hiestand B; Filippatos G; Diercks DB; Hollander J; Nowak R; Peacock WF; Gheorghiade M
    J Card Fail; 2009 Aug; 15(6):467-74. PubMed ID: 19643356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and prognostic value of uric acid in patients with acute dyspnea.
    Reichlin T; Potocki M; Breidthardt T; Noveanu M; Hartwiger S; Burri E; Klima T; Stelzig C; Laule K; Mebazaa A; Christ M; Mueller C
    Am J Med; 2009 Nov; 122(11):1054.e7-1054.e14. PubMed ID: 19854335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing validity by comparing transition and static measures of dyspnea in patients with acute decompensated heart failure.
    Smithline HA; Caglar S; Blank FS
    Congest Heart Fail; 2010; 16(5):202-7. PubMed ID: 20887616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF).
    Hernandez AF; O'Connor CM; Starling RC; Reist CJ; Armstrong PW; Dickstein K; Lorenz TJ; Gibler WB; Hasselblad V; Komajda M; Massie B; McMurray JJ; Nieminen M; Rouleau JL; Swedberg K; Califf RM
    Am Heart J; 2009 Feb; 157(2):271-7. PubMed ID: 19185633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of dyspnea in acute heart failure syndromes.
    West RL; Hernandez AF; O'Connor CM; Starling RC; Califf RM
    Am Heart J; 2010 Aug; 160(2):209-14. PubMed ID: 20691823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there a clinically meaningful difference in patient reported dyspnea in acute heart failure? An analysis from URGENT Dyspnea.
    Pang PS; Lane KA; Tavares M; Storrow AB; Shen C; Peacock WF; Nowak R; Mebazaa A; Laribi S; Hollander JE; Gheorghiade M; Collins SP
    Heart Lung; 2017; 46(4):300-307. PubMed ID: 28433323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of dyspnea early in acute heart failure: patient characteristics and response differences between likert and visual analog scales.
    Pang PS; Collins SP; Sauser K; Andrei AC; Storrow AB; Hollander JE; Tavares M; Spinar J; Macarie C; Raev D; Nowak R; Gheorghiade M; Mebazaa A
    Acad Emerg Med; 2014 Jun; 21(6):659-66. PubMed ID: 25039550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of systemic hypertension on the diagnostic performance of B-type natriuretic peptide in patients with acute dyspnea.
    Pahle AS; Sørli D; Omland T; Knudsen CW; Westheim A; Wu AH; Steg PG; McCord J; Nowak RM; Hollander JE; Storrow AB; Abraham WT; McCullough PA; Maisel A
    Am J Cardiol; 2009 Oct; 104(7):966-71. PubMed ID: 19766765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of LOw-dose DObutamine stress-echocardiography to predict cardiac resynchronization therapy response (LODO-CRT) multicenter prospective study: design and rationale.
    Muto C; Gasparini M; Iacopino S; Peraldo C; Curnis A; Sassone B; Diotallevi P; Davinelli M; Valsecchi S; Tuccillo B
    Am Heart J; 2008 Oct; 156(4):656-61. PubMed ID: 18926147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The additive value of N-terminal pro-B-type natriuretic peptide testing at the emergency department in patients with acute dyspnoea.
    van der Burg-de Graauw N; Cobbaert CM; Middelhoff CJ; Bantje TA; van Guldener C
    Eur J Intern Med; 2009 May; 20(3):301-6. PubMed ID: 19393498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Choices: a study of preferences for end-of-life treatments in patients with advanced heart failure.
    MacIver J; Rao V; Delgado DH; Desai N; Ivanov J; Abbey S; Ross HJ
    J Heart Lung Transplant; 2008 Sep; 27(9):1002-7. PubMed ID: 18765193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of the prospective, randomized, controlled multicenter Food and Drug Administration investigational device exemption study of the ProDisc-C total disc replacement versus anterior discectomy and fusion for the treatment of 1-level symptomatic cervical disc disease.
    Murrey D; Janssen M; Delamarter R; Goldstein J; Zigler J; Tay B; Darden B
    Spine J; 2009 Apr; 9(4):275-86. PubMed ID: 18774751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. End-point selection for acute heart failure trials.
    Allen LA
    Heart Fail Clin; 2011 Oct; 7(4):481-95. PubMed ID: 21925431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis.
    Maisel AS; Peacock WF; McMullin N; Jessie R; Fonarow GC; Wynne J; Mills RM
    J Am Coll Cardiol; 2008 Aug; 52(7):534-40. PubMed ID: 18687247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.